EFFECT OF METRONIDAZOLE RESISTANCE IN THE EFFICACY OF AMOXICILLIN AND METRONIDAZOLE PLUS A PPI (PAM) REGIMEN FOR TREATING H. PYLORI (HP) INFECTION. A SYSTEMATIC REVIEW AND META- ANALYSIS - Mele, MB; del Castillo, IP; Calvet, X; Cohen, H; Dacoll, C; Gisbert, JP (Helicobacter, 2013)

DESIGNING AN ANTIMICROBIAL PHOTODYNAMIC THERAPY AGAINST H. PYLORI: FROM FUNDAMENTAL CONCEPTS TO IN-VITRO ACHIEVEMENTS - M Calvino-Fernández, A G McNicholl,S Benito-Martínez; X Calvet, T Parra-Cid, D García-Fresnadillo; J P Gisbert (Helicobacter, 2013)

Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence - Gonzalez, CA; Sanz-Anquela, JM; Gisbert, JP; Correa, P (International Journal Of Cancer, 2013)

ERADICATION OF HELICOBACTER PYLORI INFECTION USING NEW TREATMENT STRATEGIES IN A HIGH-RESISTANT CLARITHROMYCIN POPULATION IN SOUTHERN SPAIN - M L González-Bárcenas, J M Navarro-Jarabo, M C García Gavilán; N Fernández-Moreno, M A Romero-Ordoñez, F M Fernández Cano, F Rivas, J P Gisbert; A Pérez (Helicobacter, 2013)

AN UPDATE ON SECOND-LINE TREATMENTS EFFICACY WHEN STANDARD TRIPLE THERAPY WITH PPI, AMOXICILLIN AND CLARITHROMYCIN HAS FAILED IN HELICOBACTER PYLORI ERADICATION - A C Marín, A G McNicholl; J P Gisbert (Helicobacter, 2013)

UPDATE ON THE EFFICACY OF TRIPLE THERAPY FOR HELICOBACTER PYLORI INFECTION AND CLARITHROMYCIN RESISTANCE RATES IN SPAIN (2007-2012) - J Molina-Infante; J P Gisbert (Helicobacter, 2013)

OPTIMIZED TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION: PRELIMINARY RESULTS - J Molina-Infante, A J Lucendo,T Angueira, I Modolell, B Gómez-Rodríguez; J Gómez-Camarero, A C Marín, A G McNicholl; J P Gisbert (Helicobacter, 2013)

Probiotics for Helicobacter pylori eradication therapy: Not ready for prime time - Molina-Infante, J; Gisbert, JP (Revista Espanola De Enfermedades Digestivas, 2013)

Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals - Alvarez, Cristina; Andreu, Montserrat; Castells, Antoni; Quintero, Enrique; Bujanda, Luis; Cubiella, Joaquin; Salas, Dolores; Lanas, Angel; Carballo, Fernando; Morillas, Juan Diego; Hernandez, Cristina; Jover, Rodrigo; et al. (Gastrointestinal Endoscopy, 2013)

Actualización de la eficacia de la terapia triple para la infección por Helicobacter pylori y de la resistencia a claritromicina en España (2007-2012) - Molina Infante, Javier; Pérez Gisbert, Javier (Gastroenterologia Y Hepatologia, 2013)

Letter: mucosal healing in ulcerative colitis - higher relevance than in Crohn's disease? - Barreiro-de Acosta, M; Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2013)

Effect of Aspirin and Antiplatelet Drugs on the Outcome of the Fecal Immunochemical Test - Bujanda, Luis; Lanas, Angel; Quintero, Enrique; Castells, Antoni; Sarasqueta, Cristina; Cubiella, Joaquin; Hernandez, Vicent; Morillas, Juan D.; Perez-Fernandez, Teresa; Salas, Dolores; Andreu, Montserrat; Carballo, Fernando; et al. (Mayo Clinic Proceedings, 2013)

Commentary: overcoming antibiotic resistance with Helicobacter pylori therapy - optimisation is the way forward - Molina-Infante, J; Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2013)

Risk of Advanced Proximal Neoplasms According to Distal Colorectal Findings: Comparison of Sigmoidoscopy-Based Strategies - Castells, Antoni; Bessa, Xavier; Quintero, Enrique; Bujanda, Luis; Cubiella, Joaquin; Salas, Dolores; Lanas, Angel; Carballo, Fernando; Diego Morillas, Juan; Hernandez, Cristina; Jover, Rodrigo; Montalvo, Isabel; et al. (Jnci-Journal Of The National Cancer Institute, 2013)

DOES PRESCRIPTION YEAR INFLUENCE THE PATTERN OF BIOLOGICS USE FOR RHEUMATOID ARTHRITIS? - J M Alvaro-Gracia, M Arredondo, A Aranguren, E Daudén, G Fernández-Jiménez,; V Meca , A Morell, J P Gisbert, F J Aspa, M J García de Yébenes, L Carmona (Annals Of The Rheumatic Diseases, 2013)

Review article: proton pump inhibitor therapy for suspected eosinophilic oesophagitis - Molina-Infante, J; Katzka, DA; Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2013)

Seguridad del tratamiento con tiopurinas y anti-TNFalpha durante el embarazo en pacientes con enfermedad inflamatoria intestinal - Moreno Otero, Ricardo (Autor o Coautor); Mate Jimenez, Jose (Autor o Coautor); Perez Gisbert, Francisco Javier (Director) Doctorando: Casanova González, María José (2013)

III Conferencia Española de Consenso sobre la infección por Helicobacter pylori - JP Gisbert, F Bermejo, D Boixeda, F Bory, L Bujanda, M Castro-Fernández; E Domínguez-Muñoz, JI Elizalde, M Forné, E Gené, F Gomollón, A Lanas, C Martín de Argila; AG McNicholl, F Mearín, J Molina-Infante, M Montoro, JM Pajares; A Pérez-Aisa, E Pérez-Trallero, J Sánchez-Delgado, X Calvet (Gastroenterologia y Hepatologia, 2013)

Relationship between levels of angiogenic and lymphangiogenic factors and the endoscopic, histological and clinical activity, and acute-phase reactants in patients with inflammatory bowel disease - Algaba A, Linares PM, Fernández-Contreras ME, Ordoñez A, Trápaga J, Guerra I, Chaparro M, de la Poza G, Gisbert JP, Bermejo F (Journal Of Crohns & Colitis, 2013)

Letter: Dry blood spots for anti-TNF treatment monitoring in IBD - Authors' reply - Chaparro, M; Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2013)

Inflammatory Bowel Disease Unclassified in Real Practice: Prevalence, Clinical Course and Therapy Requirements - F Bermejo, A Algaba, J L Cuño, B Botella, C Taxonera, M Calvo; P López-Serrano, L Ballesteros, M Chaparro, A Ponferrada Díaz, N Manceñido; A López-SanRomán, D Martín, D Olivares, Y Gonzalez-Lama; J L Pérez-Calle, G Gómez, JP Gisbert, IGuerra (Gastroenterology, 2013)

Evolution of Osteopenia and Osteoporosis Over 5 Years in Patients With Inflammatory Bowel Disease - Casals-Seoane F, Chaparro M, Maté J, Gisbert JP (Gastroenterology, 2013)

Serum Concentration of Estrogen Is Associated With Inflammatory Bowel Disease Activity - P M Linares, M Chaparro, A Algaba; JP Gisbert, M Guijarro Rojas, F Bermejo, A Urzainqui, M E Fernández Contreras (Gastroenterology, 2013)

Anemia and Inflammatory Bowel Disease: Effects of High-Dose Intravenous Iron Treatment on Hemoglobin, Activity Index and Quality of Life - J Millastre, S García-López, E Bajador, M Chaparro, F Gomollón, JP Gisbert (Gastroenterology, 2013)

Entero-Urinary Fistulas in Crohn's Disease: Prevalence and Clinical Manifestations - C Taxonera, I Fernández-Blanco, M Barreiro-de Acosta, G Bastida, A López-San Román,; O Merino, V García-Sánchez, JP Gisbert, I Marín-Jiménez, P López-Serrano; E Iglesias, J Martínez-González, M Chaparro, F Bermejo, C Saro,; L Pérez-Carazo, R Plaza, D Olivares, M Cañas, JL Mendoza (Gastroenterology, 2013)

Effectiveness of Anti-TNF Agents in the Treatment of Entero-Urinary Fistulas in Crohn's Disease - C Taxonera, I Fernández-Blanco, M Barreiro-de Acosta, G Bastida,; A López-SanRomán, O Merino, V García-Sánchez, JP Gisbert, I Marín-Jimenez; P López-Serrano, E Iglesias Flores, J Martínez-Gonzalez, M Chaparro; F Bermejo, C Saro, L Pérez-Carazo, R Plaza, D Olivares, J L Mendoza, E Rey (Gastroenterology, 2013)

Mutations in D-Loop Region of Mitochondrial DNA in Helicobacter pylori Infection - S Benito-Martínez, M Calvino-Fernández, A G McNicholl, JP Gisbert, T Parra Cid (Gastroenterology, 2013)

Helicobacter pylori Activates CD277, a New Co-Inhibitory Molecule - M Calvino-Fernández, S Benito-Martínez, A G McNicholl, JP Gisbert, T Parra Cid (Gastroenterology, 2013)

Vaccination strategies in patients with IBD - Gisbert, JP; Chaparro, M (Nature Reviews Gastroenterology & Hepatology, 2013)

Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study - Kahrilas, PJ; Howden, CW; Wernersson, B; Denison, H; Nuevo, J; Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2013)

Multicenter Prospective Observational Study to Assess the Impact of Surveillance, Prophylaxis or Treatment of the Hepatitis B (HBV) and C (HCV) Virus Infection in Patients With Inflammatory Bowel Disease (IBD) Under Anti-TNF Therapies - C Loras, JP Gisbert, C Saro, M Piqueras, C Sánchez, J Barrio, I Ordás; A Montserrat, R Ferreiro, F Fernández-Bañares, M Esteve (Gastroenterology, 2013)

When Standard Triple Therapy With PPI plus Amoxicillin plus Clarithromycin Fails in the Eradication of Helicobacter pylori, What's Next? - Marin, AC; McNicholl, AG; Gisbert, JP (Gastroenterology, 2013)

A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication) - Marin, AC; McNicholl, AG; Gisbert, JP (Expert Opinion On Pharmacotherapy, 2013)

Letter: seeking oesophageal eosinophilia among unselected patients - looking for a needle in a haystack? - Molina-Infante, J; Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2013)

14-Day, High-Dose Acid Suppression, Non-Bismuth Quadruple Therapies (Hybrid vs. Concomitant) for Helicobacter pylori Infection: A Randomized Trial - J Molina-Infante, M Romano, M Fernández Bermejo, A Federico,A G Gravina; L Pozzati, E García Abadia, C Martínez-Alcala, A Miranda, G Vinagre Rodríguez,; M Hernández Alonso, B Pérez Gallardo, F J Rancel Medina, M Gata Cuadrado, JP Gisbert (Gastroenterology, 2013)

Effect of Infliximab Treatment on an Ulcerative Colitis Experimental Model in Rat - I D Román, D Fernández-Moreno, B Hernández-Breijo, M del Val T Lobo; D Cano-Martínez, P Sanmartín-Salinas, JP Gisbert, L G Guijarro (Gastroenterology, 2013)

Quadruple therapy for Helicobacter pylori infection - Molina-Infante, J; Gisbert, JP (Lancet, 2013)

Pathophysiological bases of eosinophilic esophagitis therapy - Moreno-Borque R, Gisbert JP, Santander C (Inflammation And Allergy - Drug Targets, 2013)

Utilidad de los marcadores biológicos en la enfermedad inflamatoria intestinal - Perez Gisbert, Francisco Javier (Director) Doctorando: P Miranda (2013)

Response to Tung et al. - Chaparro, M; Gisbert, JP (American Journal Of Gastroenterology, 2013)

Letter: mucosal healing and mortality in coeliac disease - Fernandez-Banares, F; Esteve, M; Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2013)

Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature - Moreno Otero, Ricardo; Perez Gisbert, Francisco Javier; Chaparro, Maria; Trapero-Marugan, Maria; Guijarro, Mercedes; Lopez, Consuelo; Gisbert, Javier P (Journal Of Crohns & Colitis, 2013)

Safety of thiopurines and anti-TNF-alpha drugs during pregnancy in patients with inflammatory bowel disease - Casanova, M J; Chaparro, M; Domenech, E; Barreiro-de Acosta, M; Bermejo, F; Iglesias, E; Gomollon, F; Rodrigo, L; Calvet, X; Esteve, M; Garcia-Planella, E; Garcia-Lopez, S; et al. (American Journal Of Gastroenterology, 2013)

Kinetics of anti-hepatitis B surface antigen titers after hepatitis B vaccination in patients with inflammatory bowel disease - Gisbert, JP; Villagrasa, JR; Rodríguez-Nogueiras, A; Chaparro, M (Inflammatory Bowel Diseases, 2013)

Helicobacter Pylori "Test-and-Treat'' Strategy for Management of Dyspepsia: A Comprehensive Review - Gisbert, JP; Calvet, X (Clinical And Translational Gastroenterology, 2013)

Intravenous iron in inflammatory bowel diseases - Gomollon, F; Gisbert, JP (Current Opinion In Gastroenterology, 2013)

USO DE UNA COMBINACION DE AZATIOPRINA Y L-BUTIONINA-[S,R]-SULFOXIMINA EN LA PREPARACION DE UN MEDICAMENTO UTIL PARA EL TRATAMIENTO DE UN TUMOR REFRACTARIO. - GONZALEZ GUIJARRO Luis (Inventores/autores/obtentores); HERNANDEZ-BREIJO Borja (Inventores/autores/obtentores); ROMAN CURTO Irene de los Dolores (Inventores/autores/obtentores); FERNANDEZ MORENO María de los Dolores (Inventores/autores/obtentores); PEREZ GISBERT Javier (Inventores/autores/obtentores) (2013)

Therapeutic guidelines on ulcerative colitis:: A GRADE methodology based effort of GETECCU - Gomollón García, Fernando; García López, Santiago; Sicilia Aladrén, Beatriz; Pérez Gisbert, Javier; Hinojosa del Val, Joaquín Ernesto (Gastroenterologia Y Hepatologia, 2013)

Reply to Dr. Katsanos et al.'s letter - Marticorena-Álvarez P; Chaparro M; Pérez-Casas A; Gisbert J (Journal Of Crohns & Colitis, 2013)

Letter: recommendations for the management of latent tuberculosis infection in IBD patients may not be applicable in all settings - Taxonera, C; Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2013)

Tratamiento de rescate con cuádruple terapia con bismuto tras el fracaso de 2 pautas terapéuticas en la erradicación de la infección por Helicobacter PyloriTratamiento de rescate con cuádruple terapia con bismuto tras el fracaso de 2 pautas terapéuticas en la erradicación de la infección por Helicobacter Pylori - González Bárcenas, Martha Lucía; Pérez Gisbert, Javier; Romero Ordoñez, MA; Pérez Aisa, Ángeles (Revista Andaluza De Patología Digestiva, 2013)

Letter: Measurement of anti-TNF-? levels and antibodies against the drug - Chaparro, M; Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2013)

Onset of psoriasis in patients with inflammatory bowel disease treated with anti-TNF agents - Guerra, I; Gisbert, JP (Expert Review Of Gastroenterology & Hepatology, 2013)

Clinical practice guidelines for managing nonvariceal upper gastrointestinal bleeding - Gallach M., Calvet X., Lanas A., Feu F., Ponce J., Gisbert J., Brullet E., Piñera P., Castro M., Martín De Argila C., Domínguez Muñoz E., Almela P., Villanueva C., González Galilea A., Pérez Aisa A., García-Iglesias P., Gené E., Villoria A., Barkun A. (Emergencias: Revista De La Sociedad Española De Medicina De Urgencias Y Emergencias, 2013)

Guía clínica GETECCU del tratamiento de la colitis ulcerosa elaborada con la metodología GRADE - Gomollón García, Fernando; García López, Santiago; Sicilia Aladrén, Beatriz; Pérez Gisbert, Javier; Hinojosa del Val, Joaquín Ernesto (Gastroenterologia Y Hepatologia, 2013)

Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption - Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, Hirschl AM, Andersen LP, Goossens H, Glupczynski Y, Study Group participants (Gut, 2013)

Letter: should colectomy be the end-point to evaluate the effectiveness of drug therapies in severe ulcerative colitis? - Domenech, E; Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2013)

Tailored therapy with novel sequential quadruple therapies - Graham, DY; Gisbert, JP (Nature Reviews Gastroenterology & Hepatology, 2013)

Clinical Efficacy of lnfliximab in Moderate to Severe Ulcerative Colitis in a Latin American Referral Population - Juliao, F; Marquez, J; Aristizabal, N; Yepes, C; Zuleta, J; Gisbert, JP (Digestion, 2013)

Optimal H. pylori management in primary care. United European Gastroenterology (Long-term Projects). Investigador Principal - Perez Gisbert, Francisco Javier (Investigador/a) (2013)

PI12/02557 (FIS) Predicción de respuesta a corto y largo plazo al tratamiento con fármacos anti-TNF en pacientes con Enfermedad de Crohn. Estudio PREDICROHN. Investigador Colaborador - Perez Gisbert, Francisco Javier (Investigador/a) (2013)

An open label extensión study of CP-690,550 as maintenance therapy in patients with Crohn?s disease - Perez Gisbert, Francisco Javier (Otros) (2013)

Correlación entre las concentraciones de calprotectina fecal y la actividad clínica en pacientes con enfermedad de Crohn en tratamiento con fármacos anti-TNF - Perez Gisbert, Francisco Javier (Otros) (2013)

Estudio clínico para evaluar el efecto de un complemento alimenticio en el alivio de síntomas de antibioterapia en pacientes tratados para la infección por Helicobacter pylori - Perez Gisbert, Francisco Javier (Otros) (2013)

Estudio comparativo prospectivo multicéntrico aleatorizado del tratamiento endoscópico de la estenosis en la enfermedad de Crohn: Prótesis metálica autoexpadible vs dilatación con balón - Perez Gisbert, Francisco Javier (Otros) (2013)

Estudio multicéntrico, aleatorizado, doble ciego, controlado con placebo y de grupos paralelos de CP_690,550 por via oral, como tratamiento de inducción, en pacientes con Colitis Ulcerosa entre moderada y grave - Perez Gisbert, Francisco Javier (Otros) (2013)

Terapia erradicadora de H. pylori de rescate con moxifloxacino tras el fracaso de un primer tratamiento erradicado - Perez Gisbert, Francisco Javier (Otros) (2013)

The ADACAL Study: calprotectin and hsCRP as markers of a new diagnostic-therapeutic strategy that assesses mucosal Activity to individuaLize treatment and improve the prognosis of patients with Crohn?s disea treated with immunosuppressants - Perez Gisbert, Francisco Javier (Otros) (2013)

Validez de la ecografía para la detección precoz de la patología músculo-esquelética asociada a Enfermedad Inflamatoria Intestinal, mediante el estudio de la presencia de sinovitis, tenosinovitis y entesitis subclínica - Perez Gisbert, Francisco Javier (Otros) (2013)

Analysis of the protease MT1-MMP and its substrates as biomarkers in IBD - Koziol, Agnieszka; Pollan, Angela; Gonzalo, Pilar; Andrade, Norman Nunez; Linares, Pablo M.; Contreras, Maria Encarnacion Fernandez; Chaparro, Maria; Urzainqui, Ana; Sanchez-Madrid, Francisco; Gisbert, Javier P.; Arroyo, Alicia G.; (Gastroenterology, 2013)

CD277: una nueva molécula inhibidora activada en la infección por Helicobacter pylori - Calvino-Fernández, M; Benito-Martínez, S; McNicholl, AG; Gisbert, JP; Parra Cid, T (2013)

Correlación entre los niveles sistémicos de citoquinas y la calidad del semen en pacientes varones con enfermedad inflamatoria intestinal - A Algaba, P Valer, PM Linares, I Guerra, M Chaparro; P López-Serrano, ME Fernández-Contreras, G de la Poza, JP Gisbert, F Bermejo (2013)

Efectividad de los fármacos anti-TNF en el tratamiento de las fístulas enterourinarias en pacientes con enfermedad de Crohn - C Taxonera, I Fernández-Blanco, M Barreiro de Acosta, G Bastida; A López-Sanromán, O Merino, V García-Sánchez, JP Gisbert, I Marín-Jiménez; P López-Serrano, E Iglesias, J Martínez-González, M Chaparro; C Saro, F Bermejo, L Pérez-Carazo, R Plaza, D Olivares, JL Mendoza, E Rey (2013)

Efectividad de los fármacos anti-TNF en el tratamiento de las fístulas enterourinarias en pacientes con enfermedad de Crohn. Estudio URICROHN. Seleccionada para presentación oral. Premio a la mejor Comunicación Oral del Congreso - C Taxonera, I Fernández-Blanco, M Barreiro-de Acosta, G Bastida; A López-Sanromán, O Merino, V García-Sánchez, JP Gisbert, I Marín-Jiménez; P López-Serrano, E Iglesias, J Martínez-González, M Chaparro, C Saro; F Bermejo, L Pérez-Carazo, R Plaza, D Olivares, JL Mendoza, E Rey (2013)

Efectividad de los tratamientos para las fístulas perianales en pacientes con enfermedad de Crohn - B Arberas-Díez, M Chaparro, P Burgueño, I Vera; F Bermejo, I Marín-Jiménez, C Yela, P López, MD Martín, C Taxonera, B Botella; R Pajares, A Ponferrrada, M Calvo, A Algaba, L Pérez, B Casis, J Maté, JP Gisbert (2013)

Efectividad del tratamiento anti TNF-? en pacientes con enfermedad de Crohn que no han respondido a un antiTNF- ? previo. Premio ?Mejor póster del congreso? - MC R-Grau, M Chaparro, F Mesonero,M Barreiro-de Acosta, L Castro, I Vera; M Castro, E Domènech, N Manceñido, C Taxonera, JL Pérez, J Barrio, R de Francisco; O Merín, L Oltra, C Saro, F Bermejo, V García, D Ginard, A Gutiérrez, X Calvet, JP Gisbert (2013)

Efecto del IGF-1 sobre la colitis experimental - D Cano-Martínez, L Sebastián-Monasor,; ID Román, MD Fernández-Moreno, B Hernández-Breijo; MVT Lobo, P Sanmartín-Salinas, R Rodríguez, O Pastor, JP Gisbert, LG Guijarro (2013)

Efecto del tratamiento con infliximab en un modelo experimental de colitis ulcerosa en rata - ID Román, MD Fernández-Moreno, B Hernández-Breijo, MVT Lobo, D Cano-Martínez,; P Sanmartín-Salinas, J Monserrat, JP Gisbert, LG Guijarro (2013)

Effect of amoxicillin and metronidazole plus a PPI (PAM) regimen for treating H. pylori infection. A systematic review and meta-analysis - M Baylina Melé, I Puig del Castillo,X Calvet,H Cohen, C Dacoll; J P Gisbert (2013)

Effect of insulin like growth factor-1 on experimental colitis - Cano-Martínez, D, Sebastián Monasor, L, Román, ID, Fernández-Moreno,; MD, Hernández-Breijo, B, Lobo, MVT, Sanmartín-Salinas, P, Gisbert, JP, Guijarro, LG (2013)

Effectiveness of anti-TNF drugs in Crohn's disease (CD) patients who did not achieve remission with the first anti-TNF - R-Grau MC, Chaparro M, Mesonero F, Barreiro-de Acosta M, Castro L, Vera I, Castro M; Domènech E, Manceñido N, Taxonera C, Pérez JL, Barrio J, De Francisco R, Merino O; Oltra L; Saro C, Bermejo F, García V; Ginard D, Gutiérrez A, Calvet X, Gisbert JP (2013)

Effectiveness of the available therapeutic options in the treatment of perianal fistulas in patients with Crohn's disease (CD) - B Arberas-Díez, M Chaparro, P Burgueño, IVera, FBermejo, IMarín-Jiménez; C Yela, P López, MD Martín, CTaxonera, B Botella, R Pajares, APonferrrada; M Calvo, A Algaba, L Pérez, B Casis, J Maté, JP Gisbert (2013)

Entero-urinary fistulas treated with anti-tnf: outcomes and predictors of response - Taxonera, Carlos; Fernandez-Blanco, Ignacio; Barreiro-De Acosta, Manuel; Bastida, Guillermo; Martinez-Gonzalez, Javier; Merino, Olga; Garcia-Sanchez, Valle; Gisbert, Javierp; Marin-Jimenez, Ignacio; Lopez-Serrano, Pilar; Iglesias, Eva; Lopez-Sanroman, Antonio; et al. (Journal Of Gastroenterology And Hepatology, 2013)

Estudio de la proteasa MT1-MMP y de sus sustratos como biomarcadores en la Enfermedad Inflamatoria Intestinal (EII) - Koziol, A, Pollán, Á, Gonzalo, P, Núñez-Andrade, N; Linares, PM, Fernández-Contreras, ME, Chaparro, M,; Urzainqui-Mayayo, AC, Sánchez-Madrid, F, Gisbert, JP, Arroyo, AG (2013)

Estudio fase IIIb/IV abierto, prospectivo, para evaluar el efecto de la remision clinica alcanzada tras un tratamiento de inducción con mesalazina MMX® en la terapia de mantenimiento a largo plazo: resultados de la fase de inducción - G D´Haens, DT Rubin, JPGisbert, S Inglis, E Magee, D Solomón (2013)

Estudio fase IV, prospectivo, aleatorizado y comparativo entre la terapia ?secuencial? y ?concomitante? para la erradicación de H. pylori en la práctica clínica habitual - AG McNicholl, AC Marín, J Molina-Infante, M Castro, J Barrio; J Ducons, X Calvet, C de la Coba, M Montoro, F Bory, Á Pérez-Aisa; M Forné, B Ruberte, R Millán, P Aranguren, P García-Iglesias, B Belloc, X Bessa; E Sáinz, ES Marcos, E Lamas, A Figuerola, C Álvarez, JL Gisbert, JP Gisbert (2013)

Estudio fase IV, prospectivo, aleatorizado y comparativo entre la terapia ?secuencial? y ?concomitante? para la erradicación de Helicobacter pylori en la práctica clínica habitual. Seleccionada como comunicación oral - McNicholl, AG; Marín, AC; Molina-Infante, J; Castro-Fernández, M; Barrio, J; Ducons, J; Calvet, X; De la Coba, C; Montoro, M; Bory, F; Pérez Aisa, A;; Forné, M; et al. (2013)

Estudio prospectivo observacional multicéntrico para evaluar el impacto de la vigilancia, profilaxis o tratamiento de la infección por el virus de la hepatitis B (VHB) y/o C (VHC) en pacientes con enfermedad inflamatoria intestinal (EII) tributarios de terapias anti-TNF. Seleccionada como comunicación oral - C Loras, JP Gisbert, C Saro, M Piqueras, C Sánchez; J Barrio, I Ordás, A Montserrat, R Ferreiro, F Fernández-Bañares, M Esteve (2013)

Evolución de la osteopenia y la osteoporosis en pacientes con enfermedad inflamatoria intestinal tras 5 años de seguimiento - Casals-Seoane F, Chaparro M, Maté J, Gisbert JP (2013)

Expresión tisular de marcadores angiogénicos en mucosa gástrica de pacientes dispépticos en relación con la infección por Helicobacter pylori - AG McNicholl, ME Fernández-Contreras, PM Linares, AC Marín, C López Elzaurdía, JP Gisbert (2013)

Factores genéticos asociados a la respuesta a esteroides en colitis ulcerosa. Proyecto GENCU-ENEIDA - M Mañosa, E Pedrosa, J Mañé, E Ricart, E García-Planella; M Esteve, M Andreu, JP Gisbert, E Cabré, E Domènech (2013)

H. pylori inactivation and virulence gene damage using a Ru(II) sensitiser supported on glass microparticles for photodynamic therapy - M Calvino-Fernández, S Benito-Martínez, X Calvet; AG McNicholl, T Parra-Cid, JP Gisbert, D García-Fresnadillo (2013)

High dose intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement - J Millastre, S García López, E Bajador, C Castaño, MA Morales,; M Chaparro, F Gomollón, JP Gisbert (2013)

Identificación de polimorfismos de las enzimas catalasa y superóxido dismutasa manganeso y su implicación en la patogenia de la enfermedad de Crohn. Seleccionada como comunicación oral - M Iborra, I Moret, J Panés, JP Gisbert, ECabré, M Esteve; A Cañas-Ventura, E García-Planella, M Peñalva, E Busó B Beltrána (2013)

Immunohistochemical expression of Angiopoietin 1 (Ang1), CD34 and D2.40 in colon of patients with inflammatory bowel disease (IBD) and its association with endoscopic activity - Linares, PM, Fernández-Contreras, ME, Algaba, A, Guijarro Rojas, M,; Bermejo, F, Chaparro, M, Gisbert, JP (2013)

Influencia de la enfermedad inflamatoria intestinal en la fertilidad de pacientes varones. Premio a la mejor Comunicación poster del Congreso - P Valer, A Algaba, E Nieto, I Guerra, M Chaparro, P López-Serrano; E Quintanilla, B Piqueras, A Bermejo, JP Gisbert, A Páez, F Bermejo (2013)

La enfermedad inflamatoria intestinal no clasificada en la práctica real: prevalencia, curso clínico y requerimientos terapéuticos - F Bermejo, A Algaba, JL Cuño, B Botella, C Taxonera, M Calvo; P López-Serrano, L Ballesteros, M Chaparro, A Ponferrada, N Manceñido, A Bermejo,; A López-Sanromán, D Martín, D Olivares, Y González-Lama, J Lázaro Pérez-Calle,; G Gómez, JP Gisbert, I Guerra (2013)

Meta-analysis of overall risk of lymphoma in patients with inflammatory bowel disease on thiopurine therapy with inclusion of european and north american studies: differences between referral center studies and population based studies - D Kotlyar, J D Lewis, L Beaugerie, A Tierney,C M Brensinger, E V Loftus; JP Gisbert, W Blonski, M Van Domselaar, M Chaparro, S Sandilya, G R Lichtenstein (2013)

Meta-analysis of sequential versis standard triple therapy for Helicobacter pylori eradication - O P Nyssen, A G McNicholl, F Megraud,V Savarino; G Oderda, C Fallone, L Fischbach, F Bazzoliand, J P Gisbert (2013)

Mutaciones en la region D-loop del DNA mitocondrial en la infección por Helicobacter pylori - Benito-Martínez, S; Calvino-Fernández, M; McNicholl, AG; Gisbert, JP; Parra Cid, T (2013)

One-year outcomes of ustekinumab therapy in a multi-drug refractory Crohn's disease cohort - D Ginard, S Khorrami, I Marín, M Chaparro, M Aguas, J Martínez-González; JL Cabriada, V García-Sánchez, A Villoria, J Gelabert, F Casellas; A Sansó, J Riera, D Hervías, S García, E García-Planella, JP Gisbert (2013)

Prevalencia de enfermedades mediadas por inmunidad en pacientes con enfermedad inflamatoria intestinal. Estudio Aquiles - I Marín-Jiménez, F Gómez, JP Gisbert, JL Pérez-Calle, M Luján; J Gordillo, I Moral, M Andreu, L Cea-Calvo, R García-Vicuña, F Vanacloch (2013)

Relación entre el estrés oxidativo y la fragmentación mitocondrial en la infección por H. pylori - M Calvino-Fernández, S Benito-Martínez, AG McNicholl, J P Gisbert, T Parra Cid (2013)

Relación entre la concentración de estrógeno en suero y actividad de la enfermedad inflamatoria intestinal (EII) - Linares, PM, Chaparro, M, Algaba, A, Gisbert, JP, Guijarro Rojas, M,; Bermejo, F, Urzainqui-Mayayo, AC, Fernández-Contreras, ME (2013)

Relación entre la expresión de Angiopoyetina 1 (Ang1), CD34 y D2.40 en la mucosa de colon y la actividad endoscópica de la enfermedad inflamatoria intestinal (EII) - PM Linares, ME Fernández-Contreras; A Algaba, M Guijarro Rojas, F Bermejo, M Chaparro, JP Gisbert (2013)

Resultados al año de tratamiento con ustekinumab en la enfermedad de Crohn resistente a múltiples fármacos. Seleccionada como comunicación oral - D Ginard, S Khorrami, I Marín-Jiménez, M Chaparro, M Aguas, J Jiménez-González; JL Cabriada, V García-Sánchez, A Villoria, J Gelabert, F Casellas; A Sansó, J Riera, D Hervías, S García, EGarcía-Planella, JP Gisbert (2013)

Role of inflammatory bowel disease in fertility of male patients - P Valer, A Algaba, E Nieto, I Guerra, M Chaparro, P López-Serrano,; E Quintanilla, B Piqueras, A Bermejo, JP Gisbert, Á Paéz, F Bermejo (2013)

Spanish follow-up multicentric study on phenotypic, epigenetic, genetic and H. pylori virulence factors associated with the progression of gastric cancer precursor lesions - C A Gonzáez, J Sanz-Anquela,O Companioni,C Bonet, M Berdasco; C López, J Mendoza, E Collantes,G Ruiz,E Rey, F Sánchez-Ceballos, E Poves; L Espinosa, M Torres, B Madrigal, M Cuatrecases,I Elizalde,L Bujanda, A Cosme; A Ferrández, G Muñoz, V Andreu,M Paules,S Lario, M Ramírez; J P Gisbert (2013)

Toxicidad y mortalidad relacionada con la administración de ciclosporina en la colitis ulcerosa corticorefractaria: un estudio multicéntrico (ENEIDA). Seleccionada como comunicación oral - I Ordás, E Domènech, V García-Sánchez, M Peñalva, A Cañas-Ventura; O Merino, F Fernández-Bañares, F Gomollón, M Vera, A Gutiérrez; E García-Planella,JP Gisbert, M Aguas, E Gento, F Muñoz, M Aguirresarobe,C Muñoz; L Fernández, P Vilar, X Calvet, M Barreiro de Acosta, CE Jiménez, MA Montoro; J Hinojosa,C Saro, A Mir, ML de Castro, MF García-Sepulcre, F Bermejo, M Esteve (2013)

Toxicity and mortality related to the use of ciclosporin in steroid refractory ulcerative colitis: a multicentric nationwide study (ENEIDA). Seleccionada como Poster of Distinction - I Ordás, E Domènech, V García-Sánchez, M Peñalva, A Cañas, O Merino,; F Fernández-Bañares, F Gomollon, I Vera, A Gutiérrez, E Garcia-Planella, JP Gisbert; M Aguas, E Gento, F Muñoz, M Aguirresarobe, C Muñoz, L Fernández, P Vilar; X Calvet, M Barreiro-de Acosta, C E Jiménez, M A Montoro, J Hinojosa, C Saro; A Mir, L De-Castro, M FF García-Sepulcre, F Bermejo, M Esteve (2013)

Tratamiento con hierro i.v. a altas dosis en la anemia ferropénica de la enfermedad inflamatoria intestinal: efectividad e impacto en la calidad de vida - J Millastre, JP Gisbert, E Bajador, M Chaparro; C Castaño, JA García-Erce, S García, F Gomollón (2013)

Tratamiento de rescate de tercera línea con una cuádruple terapia con bismuto tras dos fracasos erradicadores (con claritromicina y levofloxacino) de H. pylori: estudio multicéntrico nacional de la Asociación Española de Gastroenterología - Gisbert, JP; Pérez Aisa, A; Rodrigo, L; Molina-Infante, J; Modolell, I; Bermejo, F;; Castro-Fernández, M; Antón, R; Sacristán, B; Cosme, A; Barrio, J; Harb, Y;; et al. (2013)

Tratamientos cuádruples sin bismuto de 14 días con dosis altas de IBP (híbrido frente a concomitante) para la infección por Helicobacter pylori: un ensayo clínico aleatorizado. Seleccionada como comunicación oral - J Molina Infante, M Romano, M Fernández Bermejo; A Federico, AG Gravina, L Pozzati, E García Abadía, C Martínez Alcalá; G Vinagre Rodríguez, M Hernández Alonso, B Pérez Gallardo; A Miranda, M Gata Cuadrado, FJ Rancel Medina, JP Gisbert (2013)

Uso de fármacos biológicos de segunda línea en esclerosis múltiple - V Meca, M Arredondo, MJ García de Yebenes, A Aranguren, E Dauden; G Fernández-Jiménez, A Morell, JP Gisbert, J Aspa, L Carmona, J Vivancos, JM Alvaro-Gracia (2013)

¿Qué hacer cuando fracasa la terapia triple con un IBP, amoxicilina y claritromicina en la erradicación de Helicobacter pylori? - Marín, AC; McNicholl, AG; Gisbert, JP (2013)

Errores frecuentes en el manejo de las formas graves de enfermedad inflamatoria intestinal?. - Perez Gisbert, Francisco Javier (Autor o Coautor) (2013)

Estudio Eneida: Actualización y futuro - Perez Gisbert, Francisco Javier (Autor o Coautor) (2013)

Optimal Management of H.pylori infection in Primary Case - Perez Gisbert, Francisco Javier (Autor o Coautor) (2013)

Uso de biológicos en enfermedades inflamatorias crónicas en el Hospital Universitario de La Princesa. Análisis histórico - Perez Gisbert, Francisco Javier (Autor o Coautor) (2013)

Revisión sistemática de la terapia secuencial frente a la triple terapia clásica para la erradicación de helicobacter pylori - Moreno Otero, Ricardo (Autor o Coautor); Mate Jimenez, Jose (Autor o Coautor); Olga Pérez Nyssen (Director) Doctorando: Olga Pérez Nyssen (2013)

Evaluación preclínica de la eficacia de la Azatioprina en el tratamiento de tumores sólidos - Perez Gisbert, Francisco Javier (Director) Doctorando: FB Hernández Breijo (2013)

Severe adalimumab-induced thrombocytopenia in a patient with Crohn''s disease - Casanova, MJ; Chaparro, M; Martínez, S; Vicuña, I; Gisbert, JP (Journal Of Crohns & Colitis, 2012)

Manejo del paciente con dispepsia. Guía de práctica clínica: Actualización 2012. Resumen ejecutivo - Pérez Gisbert, Javier; Calvet Calvo, Xavier; Ferrándiz Santos, Juan; Mascort Roca, Joan Josep; Alonso Coello, Pablo; Marzo Castillejo, Mercè (Atencion Primaria, 2012)

Clinical Efficacy of Infliximab in Moderate to Severe Ulcerative - Juliao, F; Marquez, J; Aristizabal, N; Carlos, Y; Julio, Z; Gisbert, JP (Inflammatory Bowel Diseases, 2012)

Drugs and the Upper and Lower Gastrointestinal Tract: From Inflammation To Malignancy - Gisbert, JP (Current Drug Metabolism, 2012)

Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response - Katz, Lior; Gisbert, Javier P.; Manoogian, Beth; Lin, Kirk; Steenholdt, Casper; Mantzaris, Gerassimos J.; Atreja, Ashish; Ron, Yulia; Swaminath, Arun; Shah, Somal; Hart, Ailsa; Lakatos, Peter Laszlo; et al. (Inflammatory Bowel Diseases, 2012)

The Influence of CYP2C19 Genetic Polymorphism on the Pharmacokinetics/-Pharmacodynamics of Proton Pump Inhibitor-Containing Helicobacter pylori Treatments - Serrano, D; Torrado, S; Torrado-Santiago, S; Gisbert, JP (Current Drug Metabolism, 2012)

Letter: Mucosal PCR for cytomegalovirus in refractory ulcerative colitis - Authors' reply - Chaparro, M; Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2012)

Is Medication Dose a Risk Factor for Lymphoma in IBD Patients Taking Azathioprine/6-Mercaptopurine? - D Kotlyar, JP Gisbert, M Chaparro, W Blonski, G Lichtenstein (American Journal Of Gastroenterology, 2012)

Demographic Difference of Hepatosplenic T-Cell Lymphoma (HSTCL) Versus Non-HSTCL Lymphoma in Patients with IBD Receiving Thiopurines: A Population Cohort Analysis - D Kotlyar, JP Gisbert, M Chaparro, E Loftus, Blonski, G Lichtenstein (American Journal Of Gastroenterology, 2012)

Efficacy of hepatitis b vaccination and revaccination and factors impacting on response in patients with inflammatory bowel disease - Gisbert, JP; Villagrasa, JR; Rodríguez-Nogueiras, A; Chaparro, M (American Journal Of Gastroenterology, 2012)

Letter: real-life management of new onset ulcerative colitis and proctitis - Domenech, E; Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2012)

Probable diffuse retinopathy caused by adalimumab in a patient with Crohn's disease - Marticorena-Alvarez, P; Chaparro, M; Pérez-Casas, A; Muriel-Herrero, A; Gisbert, JP (Journal Of Crohns & Colitis, 2012)

Methotrexate in inflammatory bowel disease: a multicenter retrospective study focused on long-term efficacy and safety. The Madrid experience - Gonzalez-Lama, Yago; Taxonera, Carlos; Lopez-Sanroman, Antonio; Lazaro Perez-Calle, Jose; Bermejo, Fernando; Pajares, Ramon; Mcnicholl, Adrian G; Opio, Veronica; Luis Mendoza, Juan; Lopez, Pilar; Algaba, Alicia; Estelles, Jesus; et al. (European Journal Of Gastroenterology & Hepatology, 2012)

Letter: Anti-TNFs and psoriasis - Friends or foes? - Guerra, I; Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2012)

HELICOBACTER PYLORI INFECTION INDUCES MUTATIONS IN D-LOOP REGION OF MITOCHONDRIAL DNA - S Benito-Martínez, M Calvino-Fernández, AG McNicholl, J P Gisbert, T Parra Cid (Helicobacter, 2012)

Letter: are idiopathic (non-NSAID, non-Helicobacter pylori) ulcers really increasing? - Calvet, X; Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2012)

CD277: A NEW CO-INHIBITORY MOLECULE ACTIVATED BY HELICOBACTER PYLORI - M Calvino-Fernández, S Benito-Martínez, AG McNicholl, J P Gisbert, T Parra Cid (Helicobacter, 2012)

OXIDATIVE STRESS CAUSED BY H. PYLORI DECIDES THE MITOCHONDRIAL NETWORK FRAGMENTATION BY PROTEINS TRANSLOCATION (BAX AND DRP-1) TO FISSION SITES - M Calvino-Fernández, S Benito-Martínez, AG McNicholl, J P Gisbert, T Parra Cid (Helicobacter, 2012)

Letter: are lymphocytic colitis and collagenous colitis really the same disease? - Fernandez-Banares, F; Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2012)

SECOND-LINE RESCUE TRIPLE THERAPY WITH LEVOFLOXACIN AFTER FAILURE OF QUADRUPLE NON-BISMUTH "SEQUENTIAL" OR "CONCOMITANT" TREATMENT - JP Gisbert, A C Marín, J Molina-Infante (Helicobacter, 2012)

HELICOBACTER PYLORI FIRST-LINE TREATMENT WITH CLARITHROMYCIN AND METRONIDAZOLE IN PATIENTS ALLERGIC TO PENICILLIN: IS IT AN ACCEPTABLE OPTION? - JP Gisbert, A Pérez Aisa, M Castro-Fernández, J Barrio,; L Rodrigo, A Cosme, J L Gisbert, S Marcos (Helicobacter, 2012)

Azathioprine produces senescence through desensitization to IGF 1 in human hepatoblastoma cells - Hernandez-Breijo, B; Monserrat, J; Lobo, MVT; Gisbert, JP; Guijarro, LG (Febs Journal, 2012)

Letter: infliximab and adalimumab in the management of Crohn's disease - are they really comparable? - Lopez-Sanroman, A; Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2012)

BLOOD AND LYMPHATIC MICROVESSELS DENSITY IN GASTRIC MUCOSA OF DYSPEPTIC PATIENTS - A G McNicholl, M E Fernández-Contreras; P M Linares, A C Marín, C López-Elzaurdia, M Chaparro, J P Gisbert (Helicobacter, 2012)

Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection - McNicholl, AG; Linares, PM; Nyssen, OP; Calvet, X; Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2012)

EFFICACY OF TRIPLE THERAPY INCLUDING A PPI PLUS AMOXICILLIN AND METRONIDAZOLE (PAM) FOR TREATMENT OF H. PYLORI INFECTION: PRELIMINARY REPORT OF A SYSTEMATIC REVIEW - I Puig, M Baylina, J Sánchez-Delgado, P García-Iglesias, J P Gisbert, X Calvet (Helicobacter, 2012)

HELICOBACTER PYLORI INFECTION IN SPAIN: IS ITS PREVALENCE REALLY DECREASING? - J P Gisbert, AG McNicholl (Helicobacter, 2012)

Long-Term Follow-Up of 1,000 Patients Cured of Helicobacter pylori Infection Following an Episode of Peptic Ulcer Bleeding - Gisbert, J P; Calvet, X; Cosme, A; Almela, P; Feu, F; Bory, F; Santolaria, S; Aznarez, R; Castro, M; Fernandez, N; Garcia-Gravalos, R; Benages, A; et al. (American Journal Of Gastroenterology, 2012)

Situación actual del manejo de la hemorragia digestiva alta no varicosa en España - Pérez Aisa, Ángeles; Nuevo, Javier; López Morante, Anibal Alejandro; González Galilea, Ángel; Martín de Argila de Prados, Carlos; Aviñoa Arreal, David; Borda Celaya, Fernando; Pérez Gisbert, Javier; Pérez Roldán, Francisco; Gonzalvo Sorribes, José Manuel; Palazón Azorín, José María; Ponce Romero, M; et al. (Gastroenterologia y Hepatologia, 2012)

Nonbismuth Quadruple (Concomitant) Therapy: Empirical and Tailored Efficacy versus Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori and versus Sequential Therapy for Clarithromycin-Resistant Strains - Molina-Infante, J; Pazos-Pacheco, C; Vinagre-Rodriguez, G; Perez-Gallardo, B; Dueñas-Sadornil, C; Hernandez-Alonso, M; Gonzalez-Garcia, G; Mateos-Rodriguez, JM; Fernandez-Bermejo, M; Gisbert, JP (Helicobacter, 2012)

Letter: surgery for ulcerative colitis mostly follows anti-TNF drugs - a new 'therapeutic package'? - Barreiro-de Acosta, M; Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2012)

Efficacy of different therapeutic options for spontaneous abdominal abscesses in Crohn's disease: Are antibiotics enough? - Bermejo, F; Garrido, E; Chaparro, M; Gordillo, J; Mañosa, M; Algaba, A; López-Sanromán, A; Gisbert, JP; García-Planella, E; Guerra, I; Domènech, E (Inflammatory Bowel Diseases, 2012)

Adherence of gastroenterologists to European Crohn's and Colitis Organisation Consensus on Crohn's disease: A real-life survey in Spain - Hinojosa, J; Gisbert, JP; Gomollon, F; Roman, ALS (Journal Of Crohns & Colitis, 2012)

Commentary: comparators in H. pylori eradication - stating the ethics of statins - McNicholl, AG; Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2012)

Use of A Combination of Azathioprine and L-Buthionine-[S,R]-Sulfoximine In the Preparation of A Drug Useful In the Treatment of A Refractory Tumor - Perez Gisbert, Francisco Javier (Inventores/autores/obtentores) (2012)

Letter: TPMT - not all that glitters is gold - Gonzalez-Lama, Y; Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2012)

Accuracy of Urea Breath Test Performed Immediately After Emergency Endoscopy in Peptic Ulcer Bleeding - Velayos, B; Fernandez-Salazar, L; Pons-Renedo, F; Munoz, MF; Almaraz, A; Aller, R; Ruiz, L; Del Olmo, L; Gisbert, JP; Gonzalez-Hernandez, JM (Digestive Diseases And Sciences, 2012)

Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: A report of 21 cases - Guerra, Ivan; Algaba, Alicia; Lazaro Perez-Calle, Jose; Chaparro, Maria; Marin-Jimenez, Ignacio; Garcia-Castellanos, Raquel; Gonzalez-Lama, Yago; Lopez-Sanroman, Antonio; Mancenido, Noemi; Martinez-Montiel, Pilar; Quintanilla, Elvira; Taxonera, Carlos; et al. (Journal Of Crohns & Colitis, 2012)

Letter: third-line rescue therapy with levofloxacin after failure of two treatments to eradicate Helicobacter pylori infection - J P Gisbert, M Castro-Fernández, A Pérez-Aisa, F Bermejo, J Ducons; M Fernández-Bermejo, F Bory, A Cosme, E Lamas, M Pabón (Alimentary Pharmacology & Therapeutics, 2012)

Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease - Gisbert, JP; Menchén, L; García-Sánchez, V; Marín, I; Villagrasa, JR; Chaparro, M (Alimentary Pharmacology & Therapeutics, 2012)

Evaluation of liver fibrosis by transient elastography (Fibroscan (R)) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial - Barbero-Villares, A; Jiménez-Ridruejo, JM; Taxonera, C; López-Sanromán, A; Pajares, R; Bermejo, F; Pérez-Calle, JL; Mendoza, JL; Algaba, A; Moreno-Otero, R; Maté, J; Gisbert, JP (Scandinavian Journal Of Gastroenterology, 2012)

The Effect of Infliximab and Adalimumab Treatment on Angiogenic Factor Levels in Patients With Inflammatory Bowel Disease (IBD) - A Algaba, PM Linares, ME Fernández-Contreras, A Figuerola, X Calvet,; I Guerra, JC Villa, M Chaparro,JL Rodríguez-Agulló, JP Gisbert, F Bermejo (Gastroenterology, 2012)

The Natural History of Crohn's Disease: A Long-Term (> 10 Years) Follow-up Study - F Casals-Seoane, JP Gisbert, M Chaparro (Gastroenterology, 2012)

The Natural History of Crohn's Disease: Impact of the Introduction of Thiopurines on Its Outcome - F Casals-Seoane, JP Gisbert, M Chaparro (Gastroenterology, 2012)

Has the Risk of Developing Colorectal Cancer in Patients With Ulcerative Colitis Been Overstated? a Meta-Analysis - C Castaño-Milla, M Chaparro, JP Gisbert (Gastroenterology, 2012)

Efficacy of Hepatitis B Vaccination and Re-Vaccination and Factors Impacting on the Response in Inflammatory Bowel Disease Patients - JP Gisbert, JR Villagrasa, A Rodríguez-Nogueiras, M Chaparro (Gastroenterology, 2012)

Systematic Review: Duration of Exposure to Azathioprine/6-MP as a Risk Factor for Lymphoma - D Kotlyar, J P Gisbert, M Chaparro, E V Loftus, W Blonski, G R Lichtenstein (Gastroenterology, 2012)

Immunohistochemical Expression of Angiopoietin 1 (Ang1) and Microvessels Density in Colon of Patients With Inflammatory Bowel Disease (IBD) - P M Linares, M E Fernández Contreras, A Algaba,; M Guijarro-Rojas, F Bermejo, M Chaparro, J P Gisbert (Gastroenterology, 2012)

Photodynamic Therapy: an Alternative Strategy Against Helicobacter pylori - M Calvino-Fernández, D García-Fresnadillo; S Benito-Martínez, A G McNicholl, J P Gisbert, T Parra Cid (Gastroenterology, 2012)

Safety of Immunomodulators and Anti-TNF Drugs for the Treatment of Inflammatory Bowel Disease (IBD) During Pregnancy - MJCasanova, MChaparro, EIglesias, LRodrigo, EDomènech; XCalvet, EGarcía-Planella, FBermejo, CTaxonera, MBarreiro-de Acosta, SGarcía; DGinard, JLCabriada, EGarrido, MGómez, JLPérez-Calle, CSaro, MPiqueras; BBeltrán, MEsteve, BBotella, CDueñas, VGarcía, JMaté, JPGisbert (Gastroenterology, 2012)

Dynamics of Mitochondrial Network in Helicobacter pylori Infection - T Parra Cid, M Calvino-Fernández, S Benito-Martínez, J P Gisbert (Gastroenterology, 2012)

Helicobacter pylori Toxicity: A Theoretical Model - T Parra Cid, M Calvino-Fernández, S Benito-Martínez, J P Gisbert (Gastroenterology, 2012)

Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding: Long-term follow-up study of 1,000 patients - JP Gisbert, X Calvet, A Cosme, P Almela, F Feu, F Bory,; S Santolaria, R Aznárez, M Castro, N Fernández, R García-Grávalos, A Benages; N Cañete, M Montoro, F Borda, A Pérez-Aisa, JM Piqué (Gastroenterology, 2012)

The Effectiveness of Standard Triple-Therapy for Helicobacter pylori Has Not Changed Over the Last Decade, but it is Not Good Enough - JP Gisbert, X Calvet (Gastroenterology, 2012)

Rifabutin in the Treatment of Refractory Helicobacter pylori Infection: A Review - JP Gisbert, X Calvet (Gastroenterology, 2012)

The Autophagy Produced by Azathioprine in HEPG2 Cells Leads to Apoptotic Cell Death Due to Inhibition With Bafilomycin A1 - B Hernández-Breijo, ID Román, D Fernández-Moreno, J Monserrat, J P Gisbert, L G Guijarro (Gastroenterology, 2012)

Azathioprine Produces Autophagy in Hepatoblastoma Cells by Desensitization to Insulin-Like Growth Factor 1 (IGF-1) - B Hernández-Breijo, I D Román, D Fernández-Moreno, JMonserrat, J P Gisbert, L G Guijarro (Gastroenterology, 2012)

Meta-Analysis of Studies Comparing the First and New Generation Proton Pump Inhibitors in the Eradication of Helicobacter pylori - McNicholl, AG; Linares, PM; Nyssen, OP; Calvet, X; Gisbert, JP (Gastroenterology, 2012)

Desensitization of the IGF-I Receptor Signal Transduction in Rat Colon With Experimental Colitis - I D Román, D Fernández-Moreno, B Hernández-Breijo, M V T Lobo; P Sanz-Hernanz, C L Pastor, L Sebastian, J P Gisbert, L G Guijarro (Gastroenterology, 2012)

Maintenance of Helicobacter pylori Eradication Rates With Triple Therapy Over 12 Years in a Spanish Hospital - JP Gisbert, A G McNicholl (Gastroenterology, 2012)

Meta-Analysis of Levofloxacin-Containing Triple Therapy vs. Bismuth-Containing Quadruple Therapy as Second-Line Treatment in the Eradication of Helicobacter pylori - A C Marín, A G McNicholl, J P Gisbert (Gastroenterology, 2012)

Genital fistulas in female Crohn's disease patients.. Clinical characteristics and response to therapy - de la Poza, G; Lopez-Sanroman, A; Taxonera, C; Marin-Jimenez, I; Gisbert, JP; Bermejo, F; Opio, V; Muriel, A (Journal of Crohn's and Colitis, 2012)

Letter: the ethics of using inferior regimens in H. pylori randomised trials - invited comment - Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2012)

Systematic review: Antibodies and anti-TNF-? levels in inflammatory bowel disease - Chaparro, M; Guerra, I; Muñoz-Linares, P; Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2012)

Intensification of infliximab therapy in Crohn's disease: Efficacy and safety - Chaparro, M; Martínez-Montiel, P; Van Domselaar, M; Bermejo, F; Pérez-Calle, JL; Casis, B; López-San Román, A; Algaba, A; Maté, J; Gisbert, JP (Journal Of Crohns & Colitis, 2012)

Why thiopurine metabolites are relevant: authors' reply - Gonzalez-Lama, Y; Gisbert, JP (Alimentary Pharmacology & Therapeutics, 2012)

Actualización del tratamiento médico de la enfermedad de Crohn - Chaparro M; Gisbert J (Medicine, 2012)

Tratamiento del brote de enfermedad de Crohn - Chaparro M; Gisbert J (Medicine, 2012)

Guía de práctica clínica sobre el manejo del paciente con dispepsia: Actualización 2012 - Pérez Gisbert, Javier; Calvet Calvo, Xavier; Ferrándiz Santos, Juan; Mascort Roca, Joan Josep; Alonso Coello, Pablo; Marzo Castillejo, Mercè (Atencion Primaria, 2012)

Anemia ferropénica y uso de hierro endovenoso en patología digestiva - Mearin, Fermín; Balboa Rodríguez, A; Castells, Antoni; Domínguez Muñoz, J Enrique; Esteve Comas, María; García Erce, José Antonio; Pérez Gisbert, Javier; Gomollón García, Fernando; Panés, Julián; Ponce García, Julio (Gastroenterologia Y Hepatologia, 2012)

Review article: rifabutin in the treatment of refractory Helicobacter pylori infection - Gisbert, JP; Calvet, X (Alimentary Pharmacology & Therapeutics, 2012)

Rescue Therapy for Helicobacter pylori Infection 2012 - Gisbert, JP (Gastroenterology Research And Practice, 2012)

A NOTE ON SELF-SIMILAR VECTOR FIELDS IN STATIC SPHERICALLY SYMMETRIC SPACE-TIMES - Shabbir, G; Khan, S (University Politehnica Of Bucharest Scientific Bulletin-Series A-Applied Mathematics And Physics, 2012)

Effect of treatment with adalimumab on serum levels of soluble angiogenic factors in patients with inflammatory bowel disease. AbbVie Inc. USA. Investigator Iniciated Studies Grant. Investigador Principal - Perez Gisbert, Francisco Javier (Investigador/a) (2012)

Ensayo clínico multicéntrico, prospectivo, aleatorizado y comparativo para evaluar la eficacia de dos vacunas frente al virus de la Hepatitis B en pacientes con enfermedad inflamatoria intestinal. CAIBER. Investigador Principal - Perez Gisbert, Francisco Javier (Investigador/a) (2012)

Estudio del papel de PSGL-1 en el control del desarrollo de enfermedades autoinmunes. Fundación Ramón Areces. Investigador Principal - Perez Gisbert, Francisco Javier (Investigador/a) (2012)

Estudio prospectivo, aleatorizado y comparativo para evaluar la eficacia de dos vacunas frente al virus de la hepatitis B en pacientes con enfermedad inflamatoria intestinal. Beca Gonzalo Miño de la Fundación Española de Gastroenterología. Investigador Principal. Coordinador - Perez Gisbert, Francisco Javier (Investigador/a) (2012)

Impacto de la vacuna frente al virus de la hepatitis B en el sistema inmune. V Beca GETECCU?Otsuka. Investigador Colaborador - Perez Gisbert, Francisco Javier (Investigador/a) (2012)

PI11/0148 (FIS). Caracterización de una enfermedad espontánea autoinmune desarrollada en ratones deficientes en PSGL-1. Contribución de PSGL-1 al desarrollo de enfermedades autoinmunes en humanos. Colaborador/Asesor - Perez Gisbert, Francisco Javier (Investigador/a) (2012)